CorWave news
CorWave, a French medtech company developing a nextgeneration heart pump, won the 2021 Healthtech Award in the Medtech category yesterday. Organized by France Biotech, the French professional association of healthtech entrepreneurs, the event rewards the companies that have made the biggest impact on the sector this year.
109 companies submitted applications for the 2021 Healthtech Awards. CorWave received the Medtech Award, which recognizes a medical device or diagnostic company that
CorWave, a French medtech developing a next-generation heart pump, is recruiting top talent from throughout the world to strengthen its team. Two seasoned industry experts are joining the company: Paul Cornelison (USA) as Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Michael Webb (Australia) as Vice President, Manufacturing.
Paul Cornelison and Michael Webb have previously held senior management positions at top medtech companies and successful start-
CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD). The results were presented at the 46th Annual Conference of the European Society for Artificial Organs (ESAO) in Hannover.
Trevor Snyder, PhD, Senior Director, Translational and Clinical Research at CorWave, delivered an oral presentation, “CorWave LVAD: A physiologic, pulsatile-flow wave membrane pump”, as part of the plenary sessions
CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device (LVAD) operating synchronously with the native heart without the use of sensors. The results were presented at the American Society for Artificial Internal Organs (ASAIO) Annual Meeting on June 12th, 2021, in Washington, DC, by Carl Botterbusch, CTO of CorWave.
The results o
CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT). The company presented the first ever study demonstrating sensorless synchronization of a pericardial pump with the native heart for over 30 days. This breakthrough is an important step towards the finalization of the development
Mr. Bruno Le Maire, Economy and Finance Minister and Mr. Cédric O, Secretary of State for Digital Transition and Electronic Communications, announced the selection of CorWave to join the French Tech 120 index, designed for the best French startups with the capacity to become global leaders.
CorWave is one of five medtech startups selected in the French Tech 120 index. The French government designed the program to support technology companies that have the potential to become gl
CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients. The capital increase is subscribed by returning investors joined by the EIC Fund, the European Commission`s venture capital mega-fund, which makes its first investment.
CorWave, located in Clichy, Île-de-France, is developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a breakthrough te
CorWave announced today that the latest results of its preclinical Left Ventricular Assist Device (LVAD) development program are presented at the 2020 Virtual OnDemand Conference of the American Society for Artificial Organs (ASAIO), in the Top Abstracts session, available on the ASAIO website1.
The presentation, entitled “In Silico, In Vitro and In Vivo Evaluation of the CorWave Membrane LVAD”, given by Trevor Snyder, PhD, Senior Director, Translational and Clinical Resea